1h Free Analyst Time
The publisher has been monitoring the biodefense market and it is poised to grow by $5.41 bn during 2021-2025, progressing at a CAGR of over 7% during the forecast period. Our report on the biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases and rapid increase in government funding in R&D.
The biodefense market analysis includes the application segment and geographic landscape.
The biodefense market is segmented as below:
By Application
- Anthrax
- Smallpox
- Botulism
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the growing threat of bioterrorism as one of the prime reasons driving the biodefense market growth during the next few years.
The report on biodefense market covers the following areas:
- Biodefense market sizing
- Biodefense market forecast
- Biodefense market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Application
- Market segments
- Comparison by Application
- Anthrax - Market size and forecast 2020-2025
- Smallpox - Market size and forecast 2020-2025
- Botulism - Market size and forecast 2020-2025
- Others - Market size and forecast 2020-2025
- Market opportunity by Application
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Alexeter Technologies LLC
- Alnylam Pharmaceuticals Inc.
- Altimmune Inc.
- ANP Technologies Inc.
- Bavarian Nordic AS
- Cleveland BioLabs Inc.
- Elusys Therapeutics Inc.
- Emergent BioSolutions Inc.
- General Dynamics Corp.
- GlaxoSmithKline Plc
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Application - Market share 2020-2025 (%)
- Comparison by Application
- Anthrax - Market size and forecast 2020-2025 ($ million)
- Anthrax - Year-over-year growth 2020-2025 (%)
- Smallpox - Market size and forecast 2020-2025 ($ million)
- Smallpox - Year-over-year growth 2020-2025 (%)
- Botulism - Market size and forecast 2020-2025 ($ million)
- Botulism - Year-over-year growth 2020-2025 (%)
- Others - Market size and forecast 2020-2025 ($ million)
- Others - Year-over-year growth 2020-2025 (%)
- Market opportunity by Application
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Alexeter Technologies LLC - Overview
- Alexeter Technologies LLC - Product and service
- Alexeter Technologies LLC - Key offerings
- Alexeter Technologies LLC - Key customers
- Alexeter Technologies LLC - Segment focus
- Alnylam Pharmaceuticals Inc. - Overview
- Alnylam Pharmaceuticals Inc. - Product and service
- Alnylam Pharmaceuticals Inc. - Key offerings
- Alnylam Pharmaceuticals Inc. - Key customers
- Alnylam Pharmaceuticals Inc. - Segment focus
- Altimmune Inc. - Overview
- Altimmune Inc. - Business segments
- Altimmune Inc. - Key offerings
- Altimmune Inc. - Key customers
- Altimmune Inc. - Segment focus
- ANP Technologies Inc. - Overview
- ANP Technologies Inc. - Product and service
- ANP Technologies Inc. - Key offerings
- ANP Technologies Inc. - Key customers
- ANP Technologies Inc. - Segment focus
- Bavarian Nordic AS - Overview
- Bavarian Nordic AS - Product and service
- Bavarian Nordic AS - Key offerings
- Bavarian Nordic AS - Key customers
- Bavarian Nordic AS - Segment focus
- Cleveland BioLabs Inc. - Overview
- Cleveland BioLabs Inc. - Product and service
- Cleveland BioLabs Inc. - Key offerings
- Cleveland BioLabs Inc. - Key customers
- Cleveland BioLabs Inc. - Segment focus
- Elusys Therapeutics Inc. - Overview
- Elusys Therapeutics Inc. - Product and service
- Elusys Therapeutics Inc. - Key offerings
- Elusys Therapeutics Inc. - Key customers
- Elusys Therapeutics Inc. - Segment focus
- Emergent BioSolutions Inc. - Overview
- Emergent BioSolutions Inc. - Business segments
- Emergent BioSolutions Inc. - Key offerings
- Emergent BioSolutions Inc. - Key customers
- Emergent BioSolutions Inc. - Segment focus
- General Dynamics Corp. - Overview
- General Dynamics Corp. - Business segments
- General Dynamics Corp. - Key offerings
- General Dynamics Corp. - Key customers
- General Dynamics Corp. - Segment focus
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Key customers
- GlaxoSmithKline Plc - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global biodefense market: Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the growing threat of bioterrorism.`
According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alexeter Technologies LLC
- Alnylam Pharmaceuticals Inc.
- Altimmune Inc.
- ANP Technologies Inc.
- Bavarian Nordic AS
- Cleveland BioLabs Inc.
- Elusys Therapeutics Inc.
- Emergent BioSolutions Inc.
- General Dynamics Corp.
- GlaxoSmithKline Plc
